Technologies Available for Licensing
MONOCLONAL ANTIBODIES TO EBOLA GLYCOPROTEIN
In this application are described Ebola GP monoclonal antibodies and epitopes recognized by these monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
Categories: Antibody Technologies
More Detail:Visit USPTO.GOV
Inventor(s):HART, M.; WILSON, J.; SCHMALJOHN, A.